Historical salary details - Dr. Richard S. Levy,M.D., Independent Director, Protara Therapeutics Inc
Dr. Richard S. Levy,M.D. is the Independent Director of Protara Therapeutics Inc. They also hold 2 other positions in Madrigal Pharmaceuticals Inc and Kiniksa Pharmaceuticals Ltd - Ordinary Shares - Class A.
Dr. Richard S. Levy,M.D.
Independent Director
-
Gross Remuneration
-
Current Company
Protara Therapeutics Inc
| YEAR | COMPANY | POSITION | SALARY | INCREMENT |
|---|---|---|---|---|
| 2024 | Protara Therapeutics Inc | Independent Director | - | - |
| 2024 | Madrigal Pharmaceuticals Inc | Independent Director | - | - |
| 2024 | Kiniksa Pharmaceuticals Ltd - Ordinary Shares - Class A | Independent Director | - | - |
| 2023 | Kiniksa Pharmaceuticals Ltd - Ordinary Shares - Class A | Independent Director | 459.7 K | 90.8 % |
| 2023 | Madrigal Pharmaceuticals Inc | Independent Director | 368.6 K | 53.0 % |
| 2023 | Protara Therapeutics Inc | Independent Director | 118.3 K | -3.9 % |
| 2022 | Kiniksa Pharmaceuticals Ltd - Ordinary Shares - Class A | Independent Director | 241.0 K | -30.7 % |
| 2022 | Madrigal Pharmaceuticals Inc | Independent Director | 240.9 K | -43.5 % |
| 2022 | Protara Therapeutics Inc | Independent Director | 123.1 K | - |
| 2022 | Kodiak Sciences Inc | Independent Director | - | - |
| 2021 | Kodiak Sciences Inc | Independent Director | 436.1 K | 6.6 % |
| 2021 | Madrigal Pharmaceuticals Inc | Independent Director | 426.1 K | -5.2 % |
| 2021 | Kiniksa Pharmaceuticals Ltd - Ordinary Shares - Class A | Independent Director | 347.7 K | 5.6 % |
| 2021 | Protara Therapeutics Inc | Independent Director | - | - |
| 2020 | Protara Therapeutics Inc | Independent Director | 1.2 M | 32674.3 % |
| 2020 | Madrigal Pharmaceuticals Inc | Independent Director | 449.3 K | -32.3 % |
| 2020 | Kodiak Sciences Inc | Independent Director | 408.9 K | 100.5 % |
| 2020 | Kiniksa Pharmaceuticals Ltd - Ordinary Shares - Class A | Independent Director | 329.3 K | -34.0 % |
| 2019 | Madrigal Pharmaceuticals Inc | Independent Director | 663.3 K | -73.0 % |
| 2019 | Kiniksa Pharmaceuticals Ltd - Ordinary Shares - Class A | Director | 499.2 K | - |
| 2019 | Kodiak Sciences Inc | Independent Director | 204 K | 31.0 % |
| 2019 | Protara Therapeutics Inc | Independent Director | 3.8 K | - |
| 2018 | Madrigal Pharmaceuticals Inc | Independent Director | 2.5 M | 994.1 % |
| 2018 | Kodiak Sciences Inc | Independent Director | 155.7 K | - |
| 2018 | Kiniksa Pharmaceuticals Ltd - Ordinary Shares - Class A | Independent Director | - | - |
| 2018 | Protara Therapeutics Inc | Independent Director | - | - |
| 2017 | Madrigal Pharmaceuticals Inc | Independent Director | 224.6 K | 63.3 % |
| 2017 | Kodiak Sciences Inc | Independent Director | - | - |
| 2016 | Madrigal Pharmaceuticals Inc | Independent Director | 137.6 K | - |